Review for 'Improvement of glycemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicenter, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 1 study)'

Autor: null Cheng Cai Tang
Rok vydání: 2022
DOI: 10.1111/dom.14998/v1/review3
Databáze: OpenAIRE